Results 211 to 220 of about 150,878 (257)
Some of the next articles are maybe not open access.
Polyoxometalates and Fullerenes as Anti-HIV Agents
1999The lack of proofreading ability of HIV reverse transcriptase leads to errors and the development of drug-resistant HIV variants. This has prompted a concerted research effort to find new efficacious chemotherapies that are not cross-resistant with currently approved antiviral agents.
Jeffrey T. Rhule +3 more
openaire +1 more source
Nihon rinsho. Japanese journal of clinical medicine, 2012
Since the introduction of zidovudine into HIV clinical practice in 1985, the history of antiretroviral treatment has been started. Even in well controlled patients with HIV loads under the detection limit for many years, viral load rebound could occur followed by CD4 cell count decline, if the antiretroviral treatment is interrupted.
openaire +1 more source
Since the introduction of zidovudine into HIV clinical practice in 1985, the history of antiretroviral treatment has been started. Even in well controlled patients with HIV loads under the detection limit for many years, viral load rebound could occur followed by CD4 cell count decline, if the antiretroviral treatment is interrupted.
openaire +1 more source
Dextran Sulphate, a Potent Anti-HIV Agent in Vitro Having Synergism With Zidovudine.
Lancet, The, 1987R Ueno
exaly
Perspective: The Expanding Challenge of HIV-Associated Malignancies
Ca-A Cancer Journal for Clinicians, 1992Judith E Karp, J E Karp, Samuel Broder
exaly
Development of Vaginal Rings for Sustained Release of Nonhormonal Contraceptives and Anti-HIV Agents
Contraception, 2007Brij B Saxena, Mukul Singh
exaly
Recent Studies on Natural Products as Anti-HIV Agents
Current Medicinal Chemistry, 2000Mankil Jung
exaly